» Articles » PMID: 36928601

False-positive Radioiodine Uptake After Radioiodine Treatment in Differentiated Thyroid Cancer

Overview
Journal Endocrine
Specialty Endocrinology
Date 2023 Mar 17
PMID 36928601
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: False-positive radioiodine uptake can sometimes be observed with post-radioiodine treatment (RIT) whole body scanning. Radioiodine pitfall has often been reported as being caused by benign or inflammatory disease, or, in some cases, by tumor lesions. This paper reviews the possible causes of such false-positive imaging, and suggests possible reasons for suspecting these pitfalls.

Methods And Results: Online databases, including MEDLINE (via PubMed), Embase, ISI Web of Science, Google Scholar, and Scopus, were systematically examined, using different keyword combinations: "radioiodine false-positive imaging", "131 I false-positive imaging" and " RAI false-positive imaging". An illustrative case was described. Excluding cases in which SPECT/CT was not performed, a total of 18 papers was found: 17 case reports and one series regarding false-positive iodine-131 uptake after RIT.

Conclusions: The prevalence of radioiodine pitfall was significantly reduced through the use of SPECT/CT imaging, though its possible presence has always to be taken into account. Inflammation, passive iodine accumulation, other tumors, and, sometimes, unknown causes can all potentially generate false-positive imaging. Missing detection of false-positive imaging could result in over-staging and inappropriate RIT or it could lead to the non-detection of other cancers. We examine the reasons for these possible pitfalls.

Citing Articles

Oldie but Goldie: The Fundamental Role of Radioiodine in the Management of Thyroid Cancer.

Campenni A, Siracusa M, Ruggeri R J Clin Med. 2024; 13(21).

PMID: 39518539 PMC: 11546874. DOI: 10.3390/jcm13216400.


Diagnostic Performance of [F]TFB PET/CT Compared with Therapeutic Activity [I]Iodine SPECT/CT and [F]FDG PET/CT in Recurrent Differentiated Thyroid Carcinoma.

Ventura D, Dittmann M, Buther F, Schafers M, Rahbar K, Hescheler D J Nucl Med. 2024; 65(2):192-198.

PMID: 38164565 PMC: 10858375. DOI: 10.2967/jnumed.123.266513.

References
1.
Aide N, Heutte N, Rame J, Rousseau E, Loiseau C, Henry-Amar M . Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation (131)I scintigraphy for thyroid cancer. J Clin Endocrinol Metab. 2009; 94(6):2075-84. DOI: 10.1210/jc.2008-2313. View

2.
Hannoush Z, Palacios J, Kuker R, Casula S . False Positive Findings on I-131 WBS and SPECT/CT in Patients with History of Thyroid Cancer: Case Series. Case Rep Endocrinol. 2017; 2017:8568347. PMC: 5299196. DOI: 10.1155/2017/8568347. View

3.
Yano E, Nakajo M, Jinguji M, Tani A, Kitazono I, Yoshiura T . I-131 false-positive uptake in a thymic cyst with expression of the sodium-iodide symporter: A case report. Medicine (Baltimore). 2022; 101(26):e29282. PMC: 9239621. DOI: 10.1097/MD.0000000000029282. View

4.
Avram A . Radioiodine scintigraphy with SPECT/CT: an important diagnostic tool for thyroid cancer staging and risk stratification. J Nucl Med. 2012; 53(5):754-64. DOI: 10.2967/jnumed.111.104133. View

5.
Maciejewski A, Czepczynski R, Ruchala M . False-positive radioiodine whole-body scan due to a renal cyst. Endokrynol Pol. 2018; 69(6):736-739. DOI: 10.5603/EP.a2018.0071. View